Abstract:Oral bioavailability of flavonoids (and many phenolic drugs) is severely limited by extensive first-pass glucuronidation. Here we aimed to determine the modulatory effects of commonly used pharmaceutical excipients (PEs) on UDP-glucuronosyltransferase (UGT) activities and to evaluate the potential of nanoemulsions containing a UGT-inhibitory PE for oral absorption enhancement of chrysin, a model flavonoid. The effects of PEs on glucuronidation were determined using tissue (liver and intestine) microsomes, expressed UGT1A1 enzyme, and UGT1A1-overexpressing HeLa cells. Nanoemulsions were prepared using a modified emulsification technique and subsequently characterized by particle size, zeta-potential, morphology, and in vitro drug release. Pharmacokinetic studies were performed with rats to assess the effects of nanoemulsions on the metabolism and pharmacokinetics of chrysin. Of 21 PEs, five (i.e., Brij 35, Brij 58, labrasol, sodium oleate, and Tween 20) significantly inhibited chrysin glucuronidation. Of note, sodium oleate was the most potent inhibitor of glucuronidation. Eight PEs including Tween 80 had no effects on glucuronidation of chrysin. The chrysin nanoemulsions prepared with sodium oleate (named SO-NE) were spherical or near-spherical (particle size, 83.2 nm; zeta-potential, -43.7 mV; entrapment efficiency, 89.5%). The reference nanoemulsions prepared with Tween 80 (T80-NE) were highly similar to SO-NE in terms of particle size, zeta-potential, and drug release. It was demonstrated in pharmacokinetic studies that SO-NE led to a 4.3-fold increase in systemic exposure of chrysin and a 3.5-fold increase in Cmax value, whereas T80-NE did not cause any changes in chrysin pharmacokinetics. In conclusion, sodium oleate-based nanoemulsions greatly enhanced oral absorption of chrysin. Oral absorption enhancement of chrysin was attained through targeted inhibition of first-pass glucuronidation by sodium oleate.

Extra virgin olive oil-based phospholipid complex/self-microemulsion enhances oral absorption of salvianolic acid B through inhibition of catechol-O-methyltransferase-mediated metabolism

Sophorolipid-based Microemulsion Delivery System: Multifaceted Enhancement of Physicochemical Properties of Xanthohumol.

Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Prescription Optimization and Oral bioavailability Study of Salvianolic Acid Extracts W/O/W Multiple Emulsion.

Pellets of Phospholipids and D-Glucose with Improved Intestinal Absorption and Oral Bioavailability of Salvianolic Acid B

Self-microemulsifying Drug Delivery System for Improved Oral Bioavailability of Oleanolic Acid: Design and Evaluation.

Enhanced Oral Bioavailability of Oleanolic Acid in Rats with Phospholipid Complex

Improved Oral Bioavailability and Hypolipidemic Effect of Syringic Acid via a Self-microemulsifying Drug Delivery System

Metabolism of salvianolic acid A and antioxidant activities of its methylated metabolites.

Salvianolic Acid B As A Substrate and Weak Catechol-O-Methyltransferase Inhibitor in Rats

Microemulsions Enhance the In Vitro Antioxidant Activity of Oleanolic Acid in RAW 264.7 Cells

Mechanism of enhanced oral absorption of akebia saponin D by a self-nanoemulsifying drug delivery system loaded with phospholipid complex

Bioavailability and Foam Cells Permeability Enhancement of Salvianolic Acid B Pellets Based on Drug–phospholipids Complex Technique

The effect of deep eutectic solvent on the pharmacokinetics of salvianolic acid B in rats and its acute toxicity test

Polymeric Nanoparticles Developed by Vitamin E-modified Aliphatic Polycarbonate Polymer to Promote Oral Absorption of Oleanolic Acid.

Enhancement of Absorption and Bioavailability of Echinacoside by Verapamil or Clove Oil

Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin Through Inhibition of UGT-Mediated Metabolism.

Mechanisms of Phospholipid Complex Loaded Nanoparticles Enhancing the Oral Bioavailability

Improved Oral Bioavailability Using a Solid Self-Microemulsifying Drug Delivery System Containing a Multicomponent Mixture Extracted from Salvia miltiorrhiza

Phospholipid Complex As an Approach for Bioavailability Enhancement of Echinacoside.

Microemulsions Containing Long-Chain Oil Ethyl Oleate Improve the Oral Bioavailability of Piroxicam by Increasing Drug Solubility and Lymphatic Transportation Simultaneously.